Minds and Mentors Program- R33
Key facts
- Who runs it
- University of Alabama, Tuscaloosa
- Where
- Birmingham and Tuscaloosa, United StatesSee the 4 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 240 people, planned
- Started
- 4 Jan 2022
- Expected to end
- 31 May 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Minds and Mentors
- Twelve Step Intervention Group
- Record updated
- 6 May 2026
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Age 19 and older
- Opioid Use disorder diagnosis based on DSM-V criteria in the past 30 days
- Currently receiving MOUD (e.g. methadone, naloxone, naltrexone, and buprenorphine) from an established provider
- Are within maintenance phase of MOUD (not actively detoxing)
- May meet criteria for a mood, anxiety, or other psychiatric disorder based on the DSM-V criteria. Participants on maintenance medications for a mood or anxiety disorder must be stabilized on medications for at least 2 weeks before therapy initiation
- Capable of reading and understanding English
- Able to provide written informed consent (i.e. no surrogate)
- Access to a smartphone or a computer with an internet connection
- Willing to commit to 12 group therapy sessions, baseline, and follow-up assessments for 24 weeks after the end of treatment (9- month total)
Who cannot take part
- Increases in alcohol or drug use leading to the need for a more intensive level of care (i.e., medical detoxification, inpatient)
- Inability to return for therapy sessions for four consecutive weeks
- Significant cognitive impairment
- Unstable medical conditions that contraindicate proposed treatment; Subject Exit criteria:
- Inability to manage psychiatric symptoms within the inclusion/exclusion criteria of the study (i.e., need for the initiation of maintenance psychotropic medications; development of psychosis). If it is determined, based on clinical criteria, that a participant needs to be started on maintenance medications for anxiety, mood or psychotic symptoms during the study, they will be discontinued from the treatment trial
- Women who are pregnant (does not impact eligibility post study initiation)
- Actively suicidal or homicidal
- Active psychosis and/ or
- Newly developed active suicidal or homicidal ideation
Where in United States
- Birmingham Veteran Affairs Medical CenterBirmingham, United States
- Pathway Healthcare, LLCBirmingham, United States
- Tuscaloosa Veteran Affairs Medical CenterTuscaloosa, United States
- University of AlabamaTuscaloosa, United States
About the trial
What the trial wants to find out
The proposed research effort will:
Read full original descriptionShow less
The purpose of this study is as follows:
1. Test the effectiveness of the Minds and Mentors Program in a group treatment trial in which individuals using medications for opioid use disorder (MOUD) will be randomized in blocks of five to receive either the Minds and Mentors Program (n=120) or Twelve Step Facilitation (n=120). 2. Determine whether the MiMP: a) improves adherence to MOUD b) reduces the rate of relapse and cravings c) decreases self-reported anxiety, stress, and depression and d) reduces cortisol levels and cortisol reactivity to drug cues. 3. Examine whether pre-intervention cortisol reactivity is predictive of relapse outcomes, and/ or reductions in cortisol reactivity over the course of intervention mediate relapse outcomes.
The 2 groups in the trial
- Mindfulness based relapse prevention and peer mentoringTreatment being tested
Treatment will utilize a group format. The twelve-week mindfulness based relapsed prevention group therapy intervention is co-led by a licensed counselor and a peer mentor for eight weeks, followed by group sessions led by peer mentors for an additional four weeks.
Treatment: Minds and Mentors
- 12 Step Treatment ProgramExisting treatment, for comparison
Participants in the attentional control group will attend 12 weeks of a enhanced 12 step treatment program.
Treatment: Twelve Step Intervention Group
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Mindfulness and Peer Mentoring Program to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R33 Phase)
- Record updated
- 6 May 2026